Theoretical Corrections of RDR_D and RD∗R_{D^*}

$R_{D^{(*)}}$ is the ratio of branching ratio $\overline{B} \rightarrow D^{(*)}\tau\overline{\nu}_{\tau}$ to $\overline{B} \rightarrow D^{(*)}l\overline{\nu}_{l}$. There is a gap of $2\sigma_{exp}$ or more between its experimental value and the prediction under the standard model(SM). People extend the MSSM with the local gauge group $U(1)_X$ to obtain the $U(1)_X$SSM. Compared with MSSM, $U(1)_X$SSM has more superfields and effects. In $U(1)_X$SSM, we research the decays $\overline{B} \rightarrow D^{(*)}l\overline{\nu}_{l}$ and calculate $R_{D^{(*)}}$. The obtained numerical results of $R_{D^{(*)}}$ are further corrected under $U(1)_X$SSM, which is much better than the SM predictions. After correction, the theoretical value of $R_{D^{(*)}}$ can reach in one $\sigma_{exp}$ range of the averaged experiment central value

Non-coding RNAs participate in the regulatory network of CLDN4 via ceRNA mediated miRNA evasion

AbstractThousands of genes have been well demonstrated to play important roles in cancer progression. As genes do not function in isolation, they can be grouped into “networks” based on their interactions. In this study, we discover a network regulating Claudin-4 in gastric cancer. We observe that Claudin-4 is up-regulated in gastric cancer and is associated with poor prognosis. Claudin-4 reinforce proliferation, invasion, and EMT in AGS, HGC-27, and SGC-7901 cells, which could be reversed by miR-596 and miR-3620-3p. In addition, lncRNA-KRTAP5-AS1 and lncRNA-TUBB2A could act as competing endogenous RNAs to affect the function of Claudin-4. Our results suggest that non-coding RNAs play important roles in the regulatory network of Claudin-4. As such, non-coding RNAs should be considered as potential biomarkers and therapeutic targets against gastric cancer.</jats:p

Production and Radioprotective Effects of Pyrroloquinoline Quinone

Pyrroloquinoline quinone (PQQ) was produced by fermentation of the Methylovorus sp. MP688 strain and purified by ion-exchange chromatography, crystallization and recrystallization. The yield of PQQ reached approximately 125 mg/L and highly pure PQQ was obtained. To determine the optimum dose of PQQ for radioprotection, three doses (2 mg/kg, 4 mg/kg, 8 mg/kg) of PQQ were orally administrated to the experimental animals subjected to a lethal dose of 8.0 Gy in survival test. Survival of mice in the irradiation + PQQ (4 mg/kg) group was found to be significantly higher in comparison with the irradiation and irradiation + nilestriol (10 mg/kg) groups. The numbers of hematocytes and bone marrow cells were measured for 21 days after sublethal 4 Gy gamma-ray irradiation with per os of 4 mg/kg of PQQ. The recovery of white blood cells, reticulocytes and bone marrow cells in the irradiation + PQQ group was faster than that in the irradiation group. Furthermore, the recovery of bone marrow cell in the irradiation + PQQ group was superior to that in irradiation + nilestriol group. Our results clearly indicate favourable effects on survival under higher lethal radiation doses and the ability of pyrroloquinoline quinine to enhance haemopoietic recovery after sublethal radiation exposure